一名秘鲁水手反复出现间日疟原虫疟疾复发情况。
Repeated Plasmodium vivax malaria relapses in a Peruvian sailor.
作者信息
McFarland Adam P, Sanchez Juan F, Mercado Alejandro, Ventocilla Julio A, Cavalcanti Sofia, Gonzalez Sofia, Lescano Andres G
机构信息
School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.
Department of Parasitology, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Av. Venezuela Cdra. 36 S/N. Bellavista, Callao, 03, Peru.
出版信息
Malar J. 2015 Dec 1;14:478. doi: 10.1186/s12936-015-0959-x.
Abstract
Two Plasmodium vivax recurrences in a Peruvian sailor with weight above the 60 kg (cap for primaquine dosage) highlight the importance of adequate radical cure weight dosage for patient treatment and control efforts, particularly within the military.
摘要
一名体重超过60公斤（伯氨喹剂量上限）的秘鲁水手出现两次间日疟复发，这凸显了在患者治疗和防控工作中，尤其是在军队中，采用足够的根治体重剂量的重要性。
相似文献
1
Repeated Plasmodium vivax malaria relapses in a Peruvian sailor.一名秘鲁水手反复出现间日疟原虫疟疾复发情况。
Malar J. 2015 Dec 1;14:478. doi: 10.1186/s12936-015-0959-x.
2
Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.因剂量依赖性伯氨喹耐药导致的间日疟原体重症复发：一例报告
Scand J Infect Dis. 2014 Jan;46(1):63-5. doi: 10.3109/00365548.2013.822093. Epub 2013 Aug 19.
3
Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.与耐伯氨喹间日疟原虫相关的诊断和治疗陷阱。
J Clin Microbiol. 2005 Feb;43(2):978-81. doi: 10.1128/JCM.43.2.978-981.2005.
4
Relapse of imported vivax malaria despite standard-dose primaquine therapy: an investigation with molecular genotyping analyses.尽管采用标准剂量的伯氨喹治疗，输入性间日疟仍有复发：一项采用分子基因分型分析的调查。
Clin Microbiol Infect. 2012 Jul;18(7):E232-4. doi: 10.1111/j.1469-0691.2012.03820.x. Epub 2012 Mar 27.
5
Case report: An unusual late relapse of Plasmodium vivax malaria.病例报告：间日疟原虫疟疾罕见的晚期复发。
Am J Trop Med Hyg. 2003 Feb;68(2):159-60.
6
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.利用间日疟原虫基因分型评估tafenoquine的抗复发疗效
J Infect Dis. 2016 Mar 1;213(5):794-9. doi: 10.1093/infdis/jiv508. Epub 2015 Oct 23.
7
Atypical Plasmodium vivax malaria in a traveler: bilateral hydronephrosis, severe thrombocytopenia, and hypotension.一名旅行者的非典型间日疟原虫疟疾：双侧肾积水、严重血小板减少症和低血压。
J Travel Med. 2008 Mar-Apr;15(2):119-21. doi: 10.1111/j.1708-8305.2007.00178.x.
8
Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.日本旅行者间日疟原虫和卵形疟原虫根治的最佳磷酸萘酚喹用药方案：回顾性分析。
Travel Med Infect Dis. 2015 May-Jun;13(3):235-40. doi: 10.1016/j.tmaid.2014.11.005. Epub 2014 Nov 20.
9
[How much primaquine is needed to eradicate Plasmodium vivax hypnozoites?].[根除间日疟原虫休眠子需要多少伯氨喹？]
Enferm Infecc Microbiol Clin. 2006 Jan;24(1):29-30. doi: 10.1157/13083372.
10
Hemophagocytic syndrome associated with severe Plasmodium vivax malaria in a child in Bikaner (northwestern India).印度西北部比卡内尔一名儿童中与严重间日疟原虫疟疾相关的噬血细胞综合征。
J Vector Borne Dis. 2013 Dec;50(4):318-20.
引用本文的文献
1
Population Pharmacokinetics of Primaquine in the Korean Population.伯氨喹在韩国人群中的群体药代动力学。
Pharmaceutics. 2021 May 3;13(5):652. doi: 10.3390/pharmaceutics13050652.
2
Utility of 8-Aminoquinolines in Malaria Prophylaxis in Travelers.8-氨基喹啉类药物在旅行者疟疾预防中的应用
Curr Infect Dis Rep. 2019 Nov 7;21(11):43. doi: 10.1007/s11908-019-0698-1.
本文引用的文献
1
Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.三种不同伯氨喹方案预防秘鲁亚马逊地区间日疟原虫疟疾复发的疗效
Am J Trop Med Hyg. 2014 Jul;91(1):18-26. doi: 10.4269/ajtmh.13-0053. Epub 2014 Apr 21.
2
Geographical variation in Plasmodium vivax relapse.间日疟原虫复发的地理差异。
Malar J. 2014 Apr 15;13:144. doi: 10.1186/1475-2875-13-144.
3
Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations.秘鲁间日疟原虫种群中的遗传变异和复发性寄生虫血症。
Malar J. 2014 Feb 24;13:67. doi: 10.1186/1475-2875-13-67.
4
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.泰非醌联合氯喹治疗和预防间日疟（DETECTIVE）：一项多中心、双盲、随机、2b 期剂量选择研究。
Lancet. 2014 Mar 22;383(9922):1049-58. doi: 10.1016/S0140-6736(13)62568-4. Epub 2013 Dec 19.
5
Genetic analysis of primaquine tolerance in a patient with relapsing vivax malaria.携疟原虫 1 型对伯氨喹敏感性的基因分析：一位复发型间日疟患者的案例报告
Emerg Infect Dis. 2013 May;19(5):802-5. doi: 10.3201/eid1905.121852.
6
Evidence and implications of mortality associated with acute Plasmodium vivax malaria.急性间日疟原虫疟疾相关死亡率的证据和影响。
Clin Microbiol Rev. 2013 Jan;26(1):36-57. doi: 10.1128/CMR.00074-12.
7
Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil.在巴西非疟区的里约热内卢旅行医学中心发生间日疟复发。
Malar J. 2012 Jul 28;11:245. doi: 10.1186/1475-2875-11-245.
8
Determinants of relapse periodicity in Plasmodium vivax malaria.影响间日疟复发周期性的因素。
Malar J. 2011 Oct 11;10:297. doi: 10.1186/1475-2875-10-297.
9
Subdoses of primaquine in overweight patients and malaria vivax relapses: report of two cases in the Federal District, Brazil.超重患者中低剂量的伯氨喹与间日疟复发：巴西联邦区两例报告。
Rev Soc Bras Med Trop. 2010 Nov-Dec;43(6):749-50. doi: 10.1590/s0037-86822010000600033.
10
Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia.农村亚马逊地区间日疟原虫的复发性寄生虫血症和种群动态。
Am J Trop Med Hyg. 2009 Dec;81(6):961-8. doi: 10.4269/ajtmh.2009.09-0337.
Zotero 插件